Barriers to Cervical Cancer Screening

May 16, 2025 updated by: Mayo Clinic
This study evaluates barriers to cervical cancer screening among non-compliant women.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

PRIMARY OBJECTIVE:

I. To further identify barriers to cervical cancer screening in women, we will identify non-compliant patients and survey them to better understand barriers that have led to inadequate screening.

OUTLINE: This is an observational study.

Participants complete a survey on study.

Study Type

Observational

Enrollment (Actual)

2216

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Minnesota
      • Rochester, Minnesota, United States, 55905
        • Mayo Clinic in Rochester

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Women aged 21-65 that are non-compliant for cervical cancer screening within the Mayo Clinic Health System

Description

Inclusion Criteria:

  • Women between the ages of 21-65
  • Non-compliant for cervical cancer screening within Mayo Clinic Primary Care

Exclusion Criteria:

  • Women less than 21 or older than 65
  • Complaint for cervical cancer screening within Mayo Clinic Primary Care
  • Women who decline participation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Observational
Participants complete a survey on study.
Other: Non-Interventional Study
Non interventional study

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Identify barriers to cervical cancer screening
Time Frame: Baseline
Participants will receive a brief "Pap Smear Barriers Survey" (likely completed in 5-15 minutes) which asks yes/no/no preference questions regarding potential barriers to cervical cancer screening. Responses will be compared regionally and by Mayo Clinic Health System site.
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Mayo Clinic

Investigators

  • Principal Investigator: Brittany A. Strelow, DSMc, PA-C, Mayo Clinic in Rochester

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 23, 2023

Primary Completion (Actual)

October 28, 2023

Study Completion (Actual)

October 28, 2023

Study Registration Dates

First Submitted

February 22, 2024

First Submitted That Met QC Criteria

February 28, 2024

First Posted (Actual)

February 29, 2024

Study Record Updates

Last Update Posted (Actual)

May 21, 2025

Last Update Submitted That Met QC Criteria

May 16, 2025

Last Verified

May 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 22-004500 (Other Identifier: Mayo Clinic Institutional Review Board)
  • NCI-2024-00181 (Registry Identifier: CTRP (Clinical Trial Reporting Program))

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe